IDENTIFICATION OF NOVEL SEQUENCES OF THE ERVMER34-1 HUMAN ENDOGENOUS RETROVIRAL SEQUENCE FAMILY, AND MODIFICATION OF THOSE SEQUENCES FOR A MORE EFFECTIVE ANTI-CANCER VACCINE AND OTHER POTENTIAL ANTI-CANCER THERAPIES | Technology Transfer

IDENTIFICATION OF NOVEL SEQUENCES OF THE ERVMER34-1 HUMAN ENDOGENOUS RETROVIRAL SEQUENCE FAMILY, AND MODIFICATION OF THOSE SEQUENCES FOR A MORE EFFECTIVE ANTI-CANCER VACCINE AND OTHER POTENTIAL ANTI-CANCER THERAPIES

Technology

E-056-2023

Patent ID

E-056-2023-0-PCT-01

Country

PCT

Application Type

PCT

Patent Status

Pending

Patent Number

Publication Number

Application Number

PCT/US2024/039057

IC

NCI

Date Filed

2024-07-22

Date Issued

Patent PDF